Intriguingly, acute treatment with aducanumab in APP/PS1 mice resulted in decrease in amyloid and LAMP1-associated neuritic dystrophy but was accompanied by increased microglial association with plaques, suggesting a more complex relationship between glial recruitment and plaque development and clearance (Cadiz et al., 2024). The gene discussed is LAMP1; the disease is amyloidosis.